Literature DB >> 9269156

Total hip arthroplasty for avascular necrosis and degenerative osteoarthritis of the hip.

T A Xenakis1, A E Beris, K K Malizos, T Koukoubis, J Gelalis, P N Soucacos.   

Abstract

Although several studies of various treatment modalities have been reported during the past decade, osteonecrosis of the femoral head remains a difficult therapeutic problem. Total hip replacement which is reserved for patients showing collapse of the femoral head, usually shows poorer results in patients with osteonecrosis compared with those with osteoarthritis. Uncemented total hip arthroplasty was performed on 29 patients with avascular necrosis of the femoral head and 29 patients with degenerative osteoarthritis. After a mean followup of 7.6 years and 7.1 years for the two groups of patients, only one failure was observed in one patient with osteonecrosis. Clinical evaluation after cementless total hip arthroplasty in both groups of patients revealed improvement in all parameters. Postoperatively, pain improved from 1.4 to 5.1, walking ability from 3.4 to 5.3, and range of motion from 4.5 to 5.5 in patients with osteonecrosis, and pain improved from 1.2 to 5.3, walking ability from 3.2 to 5.4, and range of motion from 3.1 to 4.7 in patients with osteoarthritis. Thigh pain was observed postoperatively in only two and three patients treated for osteonecrosis and osteoarthritis, respectively. The present results using cementless arthroplasty seem to be somewhat better than those reported for cemented arthroplasty in patients suffering from osteonecrosis. The clinical and radiographic findings after noncemented arthroplasty in patients with osteonecrosis of the femoral head and in patients with degenerative arthritis of the hip were similar in the two groups.

Entities:  

Mesh:

Year:  1997        PMID: 9269156

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  9 in total

1.  Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits.

Authors:  Pengde Kang; Hong Gao; Fuxing Pei; Bin Shen; Jing Yang; Zongke Zhou
Journal:  Int J Exp Pathol       Date:  2010-03-26       Impact factor: 1.925

2.  Osteogenic abilities of bone marrow stromal cells are not defective in patients with osteonecrosis.

Authors:  Jeong Joon Yoo; Won Seok Song; Kyung-Hoi Koo; Kang Sup Yoon; Hee Joong Kim
Journal:  Int Orthop       Date:  2008-02-19       Impact factor: 3.075

Review 3.  Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: a systematic literature review.

Authors:  Henning R Johannson; Michael G Zywiel; David R Marker; Lynne C Jones; Mike S McGrath; Michael A Mont
Journal:  Int Orthop       Date:  2010-02-25       Impact factor: 3.075

4.  Osteonecrosis of the femoral head: An update in year 2012.

Authors:  Anjan P Kaushik; Anusuya Das; Quanjun Cui
Journal:  World J Orthop       Date:  2012-05-18

5.  Minimally Invasive Surgery to Remove a Broken and Retained Epidural Catheter Fragment.

Authors:  Sarthak Walia; Tushar Pisal; Anirudh Kandari; Purvam Jivrajani
Journal:  Cureus       Date:  2022-05-23

6.  SAS weekly rounds: avascular necrosis.

Authors:  Thomas W Hamilton; Susan M Goodman; Mark Figgie
Journal:  HSS J       Date:  2009-03-18

7.  Survivorship of monoblock trabecular metal cups in primary THA : midterm results.

Authors:  Konstantinos N Malizos; Konstantinos Bargiotas; Loukia Papatheodorou; Michael Hantes; Theofilos Karachalios
Journal:  Clin Orthop Relat Res       Date:  2008-01-03       Impact factor: 4.176

8.  Treatment of femoral head osteonecrosis in the United States: 16-year analysis of the Nationwide Inpatient Sample.

Authors:  Aaron J Johnson; Michael A Mont; Audrey K Tsao; Lynne C Jones
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

9.  Outcome after tantalum rod implantation for treatment of femoral head osteonecrosis: 26 hips followed for an average of 3 years.

Authors:  Sokratis E Varitimidis; Apostolos P Dimitroulias; Theophilos S Karachalios; Zoe H Dailiana; Konstantinos N Malizos
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.